EAGLE-2, for instance, demonstrated a 50.6% treatment success rate in patients given gepotidacin versus 47% in nitrofurantoin counterparts ... Soleno’s diazoxide choline drug is an extended-release ...

Blujepa is the first in a new class of oral antibiotics in 30 years. It is expected to launch in the second half of 2025 in the United States.

This antibiotic is the first new FDA-approved medication for urinary tract infections in decades, and meets the need for new ...

The approval of gepotidacin (Blujepa; GSK) introduces the first new class of oral antibiotics for uncomplicated urinary tract ...

The FDA approved gepotidacin for the treatment of uncomplicated UTIs in women and adolescent girls aged 12 years or older, ...

GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of ...

Blujepa, which treats UTIs in female patients aged 12 and up with common and uncomplicated infections, will hit the market in ...

One element of that release confirmed the iPhone software was set for release in April. ForbesiOS 18.4 Release Date: Apple Surprisingly Confirms iPhone Update And New AppBy David Phelan We can pin ...

AMTD Group Inc. ("AMTD" or the "Group"), alongside World Media and Entertainment Universal Inc. ("WME"), a subsidiary of the Group under AMTD Digital, jointly announced that AMTD’s latest movie ...

This expanded indication for Amvuttra makes it the first and only FDA-approved treatment for transthyretin amyloidosis with ...

"The approval of Blujepa is a crucial milestone, with uUTIs among the most common infections in women," Tony Wood, chief scientific officer at GSK, said in a press release. "We are proud to have ...

Nintendo Switch 2 release date theory suggests May 2025 launch ... that it wouldn't want them just sitting in warehouses for an extended period of time. It also addresses the previous theory ...